Compare HOUR & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOUR | CVRX |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.3M | 81.3M |
| IPO Year | 2021 | 2021 |
| Metric | HOUR | CVRX |
|---|---|---|
| Price | $1.82 | $2.83 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.50 |
| AVG Volume (30 Days) | 7.7K | ★ 918.8K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 150.00 | 23.02 |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $142,440,236.00 | $56,651,000.00 |
| Revenue This Year | N/A | $17.17 |
| Revenue Next Year | N/A | $17.69 |
| P/E Ratio | $37.80 | ★ N/A |
| Revenue Growth | 3.03 | ★ 10.45 |
| 52 Week Low | $1.67 | $2.20 |
| 52 Week High | $4.16 | $11.30 |
| Indicator | HOUR | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 46.07 | 37.40 |
| Support Level | $1.74 | $2.20 |
| Resistance Level | $2.04 | $3.33 |
| Average True Range (ATR) | 0.08 | 0.22 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 31.82 | 12.12 |
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.